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Introduction
According to the current model on the origin and segregation of the mammalian germline, mainly based on studies carried out in the mouse embryo, the germ cell precursors termed "primordial germ cells" (PGCs) are first specified in the epiblast (around 6.25 dpc) and then determined within the allantois at the base of the yolk sac (around 7.5 dpc). Subsequently, definitively germline segregated PGCs move to the gonadal ridges where between 12.5 and 14.5 dpc, they differentiate into female or male gametes according to sex (for a review, see De Felici, 2009 and Downs, 2014) .
A number of studies carried out mainly in the mouse have shown that germline specification is an instructive process in which the proximal epiblast cells of the egg cylinder that give rise to germ cells must be primed by signaling molecules, namely the bone morphogenetic proteins (BMPs), before they acquire competence to give rise to germ cells (Lawson and Hage, 1994; Lawson et al., 1999) . Such competence is first marked by the expression of Blimp1 (also known as Prdm1) and just after by Iftm3 (also known as Fragilis) genes (Ohinata et al., 2005; Saitou et al., 2002) . As gastrulation begins (about 6.5 dpc), the Blimp1/Iftm3 expressing population moves in the caudal region of the embryo, traversing the primitive streak and exiting it alongside the extraembryonic mesoderm of the allantois. At about 7.5 dpc, approximately 50 cells settled at the base of the allantois and exhibiting high alkaline phosphatase (AP) activity are thought to be definitively segregated into a distinct germline (Ginsburg et al., 1990; Saitou et al., 2002) . This process is also associated with the expression of the Octamer-binding transcription factor 3/4 (OCT3/4, Rosner et al., 1990; Schöler et al., 1990) and mainly by the Developmental pluripotencyassociated protein 3 (DPPA-3, also known as STELLA, Saitou et al., 2002) . During this period and up to the time of their differentiation into gametes within the developing gonads, PGCs undergo extensive proliferation and a wide global genome reprogramming. The latter is believed to be necessary to reestablish pluripotency and provide a hypomethylated DNA status on which new imprinted marks can be imposed throughout subsequent gametogenesis in a sex-dependent manner. At the same time, considering the latent PGC pluripotency manifested by the expression of several markers of pluripotent stem cells, robust mechanisms ensuring that they do not undergo differentiation into somatic cell lineages or revert to an overtly pluripotent status are believed to be active (for a review, see De Felici, 2009 , 2011 .
Recently, the view that all Blimp-1, Oct3/4 and Stella expressing cells are lineage-restricted germline PGCs has been challenged by a number of observations. In fact, these markers are constitutively expressed in the inner cell mass of the mouse blastocyst and mouse embryonic stem (ES) cells (Hayashi et al., 2008) . Moreover, STELLA-and OCT3/ 4-positive cells localize to a number of embryonic tissues outside of the PGC route (Anderson et al., 2000; Downs, 2008; Mikedis and Downs, 2012; Payer et al. 2006) and seem able to contribute to multiple cell types within the posterior region of the embryo or in vitro (Bosman et al., 2006; Furuta et al., 2006; Mikedis and Downs, 2012) . In this regard, Downs 2012, 2014) , suggested that Stella and Oct3/4 expression could mark a larger stem cell population, termed the Allantoic core domain (ACD) cells, with a wide differentiation capability. These authors observed that while in ectopic grafting experiments PGC markers have been used to identify PGCs, cells exhibiting these markers have never been experimentally verified as a lineage-restricted germline. Likewise, they claimed that the maintenance of PGC identity in ectopic sites has not been unequivocally demonstrated. Other results support the view that PGCs are in fact a heterogeneous population with distinct properties. For example, Morita-Fujimura and colleagues (Morita-Fujimura et al., 2009) found that mouse migratory PGCs are heterogeneous for the expression of integrin α6 and c-KIT receptor and that PGCs with negative or low integrin α6 expression and with side population (SP) cell phenotype showed higher potential to convert to pluripotent embryonal germ (EG) cells.
In the present paper, starting from the observation of heterogeneous expression of the GOF-18ΔPE-GFP Pou5f1 (Oct3/4) transgene in FACS analyses of putative mouse PGC populations settled in the embryonic aorta-gonad-mesonephros (AGM) region, we identified various OCT3/4 positive populations showing distinct expression of PGC markers and coexpressing several proteins/genes of hematopoietic precursors. In particular, we found that Oct3/4-GFP weak weak/high cells co-expressing PGC markers as TG-1 and AP and hematopoietic stem cell (HSC) markers as FLK-1, and CD-34 and shared PGC/HSC markers such as c-KIT and PECAM-1, showed robust hematopoietic colony forming activity (CFU) in vitro. These data are discussed given the current model of germline segregation.
Results

Heterogeneity of GOF-18ΔPE-GFP Pou5f1 expression in putative PGC populations
The Pou5f1 gene, also termed Oct3/4, encodes a transcription factor considered the gatekeeper of the pluripotent state in mammals. In the mouse, the GOF-18ΔPE-GFP Pou5f1 transgene in which the reporter expression is driven by the distal enhancer of the Oct3/4 promoter, has been used to show that Oct3/4 expression marks primordial germ cells (PGCs) from their specification (about 7.5 dpc) until their arrival to the gonadal ridges (GRs) (12.5 dpc) (Anderson et al., 2000; Yeom et al., 1996) . In order to investigate possible developmental changes in the expression of the transgene, hereafter termed Oct3/4ΔPE-GFP, in the putative PGCs, 8.5 dpc caudal regions (CRs) (containing allantois and proximal hindgut) and 10.5-11.5 dpc aorta-gonad mesonephros (AGM), were isolated from transgenic Oct3/4ΔPE-GFP embryos and analyzed by FACS. The results showed that at 8.5 dpc Oct3/4ΔPE-GFP positive cells represent a rather homogeneous population expressing moderate (Oct3/4-GFP weak ) levels of the transgene in comparison with 10.5 and 11.5 dpc AGM in which, besides the Oct3/4-GFP weak population, the transgene was expressed at higher level (Oct3/4-GFP high ) in a second and prevalent population. While the percentage of the Oct3/4-GFP positive (Oct3/4-GFP pos ) including both Oct3/4-GFP weak and Oct3/4-GFP high cells in the cell samples examined increased through the embryo ages (0.8% +0.02% at 8.5 dpc; 1.4% +0.07 at 10.5 dpc: 16.5% +1.5 at 11.5 dpc), the ratio between the two populations expressing different transgene levels remained quite constant, Oct3/4-GFP weak representing between 9% and 12% of the whole Oct3/ 4-GFP pos cells (Fig. 1 ).
In 13.5-14.5 dpc ovaries and testes, heterogeneous expression of the Oct3/4 transgene was observed, likely due to the progressive down regulation of the Oct3/4 gene (Pesce et al., 1998) , and a clear separation of the Oct3/4-GFP weak and Oct3/4-GFP high populations was no more evident ( Fig. S1 ). Felici, 2011) . In particular, the BLIMP-1/PRMT-5 complex appears responsible for the progressive arginine residue symmetrical methylation of histone H2A/H4 (H2A/H4R3me2s), in PGCs from 8.5 to 11.5 dpc, a modification that may function in the transcriptional repression of target genes (Ancelin et al., 2006; Hajkova et al., 2008) . Using specific antibodies against methylated H2A/H4Rme2s, we observed three distinct nuclear morphologies termed by us dispersed, compacted and foci staining for the modified histone in virtually all FACS sorted Oct3/4-GFP high and Oct3/4-GFP weak cells.
Analysis of PGC markers in
In the latter, however, a significant higher percentage of the foci staining was detected (30 +1.7 vs 10 +1.8) (see also, Fig. S2 and Table S2 ).
Hematopoietic markers in Oct3/4ΔPE-GFP pos cells
PGC precursors emerge from epiblast cells together with hemogenic extraembryonic mesodermal cells (Hayashi et al., 2007; Huber et al., 2004) . In the hypothesis that the Oct3/4ΔPE-GFP pos cells or a subset of them could represent a not fully germline determined population also able to enter the hematopoietic lineage, we investigated the expression of early hematopoietic markers in AGM populations and their association with the Oct3/4GFP pos cells. We first FACS analyzed the expression of CD-34, CD-41 and FLK-1 because these molecules are expressed by embryonic hematopoietic progenitors (Emambokus and Frampton, 2003; Fehling et al., 2003; Ferkowicz et al., 2003; Lin et al., 2005; Matsubara et al., 2005; Mikkola et al., 2003; Tavian et al., 1996) . CD-34 expressing cells were detected in both Oct3/4-GFP neg (20% ± 2.8) (not shown) and Oct3/ 4-GFP pos cell fractions (6% ± 2.3) obtained from 10.5 dpc AGM ( ) and weak (Oct3/ 4-GFP weak CD-34 weak ) CD-34 levels, representing 6% ± 1.7 and 13% ± 1.7 of the cells, respectively ( Fig. 4 and Table S3 ). As for FLK-1 and CD-41, we surprisingly found that the first marker was expressed by the majority of the Oct3/4-GFP pos cells (85.5% ± 2.8) (Fig. 5 ), whereas CD-41 was expressed in Oct3/4-GFP neg (2.7% ± 0.08) and at much lesser extent in Oct3/ 4-GFP pos cells (0.045% ± 0.05) (not shown). In the latter, Oct3/ 4-GFP high and Oct3/4-GFP weak cells were 0.4% ± 0.08 and 9.9% ± 1.9
positive for the marker, respectively (Fig. 5) . Similar results were obtained for 11.5 dpc AGM (not shown). Using cytometry and/or IF, we also found that CD-45 and SCA-1, two other markers of early hematopoietic cells Miles et al., 1997; Nobuhisa et al., 2012) , were present in a small fraction (about 1-2%) of the Oct3/4-GFP neg cells from AGM (data not shown). On the other hand, CD-45 was not detectable in Oct3/4-GFP pos cells while SCA-1 was present in less than 1% of the Oct3/4-GFP weak cells (Fig. S2) . Conversely, most parts of the Oct3/4-GFP pos from AGM showed expression of both c-KIT and PECAM-1 (or CD-31), a tyrosine kinase receptor and an adhesion protein co-expressed by both presumptive PGCs and hematopoietic stem cells (Besmer, 1991; Cairns et al., 2003; Schmahl et al., 2000) ( Fig. S3 and Table S4 ). By RT-PCR, we analyzed the expression of other genes known to be expressed in mesodermal cells and/or embryonic hematopoietic progenitors such as Brachyury, Hox-B4, Scl/Tal-1 and Gata-2 (Dzierzak and Medvinsky, 2008; Forrester and Jackson, 2012; Robertson et al., 2000) , in Oct3/4-GFP pos and Oct3/4-GFP neg cell populations obtained from both 10.5 and 11.5 dpc AGM. The results shown in Fig. 6 indicate that, Brachyury mRNA was detected only in Oct3/4-GFP pos cells and Scl/Tal-1 in Oct3/ 4-GFP neg cells, Hox-B4 and Gata-2 transcripts were present in both cell populations. In particular, Gata-2 mRNA was detectable both in Oct3/4-GFP high and Oct3/4-GFP weak populations. Table S1 ). A subset of STELLA negative cells (about 30%) was present in Oct3/4-GFP weak cells (f, j, arrows) (see Table S1 ). Pictures were acquired with a Zeiss Axyoplan II fluorescence microscope using a 40× (e, h) or a 60× (i, l) objectives.
2.5.
Oct3/4ΔPE-GFP weak cells possess hematopoietic colony-forming unit (CFU) activity
The expression of several hematopoietic markers in Oct3/ 4-GFP pos cells, prompted us to investigate their ability to give rise to hematopoietic colonies in vitro. In order to analyze such capability, a short-term colony forming unit (CFU) assay was performed. FACS selected cell population, from AGM or GRs were cultured for 7-10 days in methylcellulose in the presence of SCF, IL-3 and EPO and tested for colony formation. The total number of colonies as well the percentage of colonies of granulocytes (CFU-G), macrophages (CFU-M), erythroids (CFU-E), granulocytes/macrophages (CFU-GM), mixed granulocytes/macrophages/erythroids (CFU-Mix) and small round non adherent cells with undifferentiated morphology (blastic cells, BCs, Mukouyama et al., 1998) , was scored after 7-10 days of culture (Fig. S4) .
As shown in Fig. 7 ), that was in the range of that previously reported for mouse AGM cells of the same ages under in vitro culture conditions similar to ours (Mukouyama et al., 1998; Takeuchi et al., 2002) . Notably, the CFU activity within the latter was almost entirely attributable to the Oct3/4-GFP weak cells (3 + 1.5/ 10 3 colonies/cells), whereas Oct3/4-GFP high were unable to give rise to colonies (not shown). In the subset Oct3/4-GFP weak CD-34 pos , the CFU activity was significantly increased (p < 0.05%) to about 9 + 2.5/10 3 (colonies/cells). As noted, we also found that cells purified from 10.5-11.5 dpc AGM using TG-1 immunomagnetic sorting (Pesce and De Felici, 1995) , showed CFU activity similar to Oct3/4-GFP pos cells (about 1.5/10 3 ) whereas both Oct3/4-GFP pos FACS or TG-1 pos immunomagnetic cells sorted from 13.5 to 14.5 dpc gonads did not showed any significant CFU activity (Fig. S5 ).
The derivation of hematopoietic colonies from all cell population tested was completely dependent on the presence of SCF in the culture medium, while LIF was dispensable (data not shown). In addition erythroid colonies were obtained exclusively when EPO was added to the culture medium (Table S5) .
Discussion
The POU domain transcription factor OCT3/4 was first associated with the germ cell line when Oct3/4 transcripts and protein were detected in the germ cells of the embryonic mouse gonads (Schöler et al., 1989 (Schöler et al., , 1990 . Oct3/4 expression was also found at 8.5 dpc in the posterior region of the mouse embryo in a pattern similar to that of AP activity associated with nascent PGCs (Schöler et al., 1990) . The results of the present paper show a progressive increased expression of the GOF-18ΔPE-GFP Pou5f1 transgene in cell populations obtained from the caudal region of 8.5 dpc embryos and 10.5-11.5 dpc AGM and co-expression in such cells of several PGC and HSC markers. Moreover, quite surprisingly, we report the presence within these populations of a subset of cells with low transgene expression and robust hematopoietic CFU activity.
Based on the literature, we offer several explanations for our observations of heterogeneity within a cell population that has previously been thought to be segregated in PGCs within the base of allantois.
First, it is possible that the heterogeneity of the transgene expression in the putative PGCs reflects incomplete differentiation of a subset of their precursors: upregulation of Oct3/4 expression might be associated with germline segregation while lower level of the transgene should mark incomplete segregation and maintenance of differentiation plasticity of mesodermal cells from which PGC precursors arise, thus allowing a subset of the putative PGC population to enter various lineage, in particular, the hematopoietic pathway. This is in line with the emerging idea that in pluripotent stem cells Oct3/4 acts in a gene dosage-dependent manner as a transcriptional organizer in a complex network of tissuespecific transcription factors (Brehm et al., 1997; Nichols et al., 1998; Niwa et al., 2000 Niwa et al., , 2005 . Interestingly, Okamura et al. (2008) reported that mouse epiblast cells with reduced expression level of Oct3/4 were able to form PGC precursors but failed to form PGCs. Actually, heterogeneous BLIMP-1 expression and the presence of a subset of STELLA negative cells in the Oct3/4-GFP weak found by us might result from incomplete germ cell segregation. In all species, PGC specification and determination involve both the induction of a germ cell-specific program and the repression of genes instructing somatic fates. In the mouse embryo, all the Blimp1-positive PGC precursors initially express somatic Hox genes (Kurimoto et al., 2008; Yabuta et al., 2006) . However, from 6.75 dpc onward, Blimp1-positive cells begin to repress the Hox genes and express Oct3/4, Sox2, Stella, and Nanog (Kurimoto et al., 2008; Yamaguchi et al., 2005) . In Blimp1-knockout embryos, AP-positive PGC-like cells are present, but they are smaller in number, do not show a migratory phenotype, and are unable to properly express PGC-specific genes (Ohinata et al., 2005; Vincent et al., 2005) . A single-cell cDNA microarray analysis has shown that, in the absence of Blimp1, nearly all of the somatic genes fail to be repressed, whereas approximately half of the specification genes are up-regulated normally (Kurimoto et al., 2008) . Moreover, cells positive for Stella repress the expression of Hox genes, whereas Iftm3-positive but Stella-negative cells retain Hox gene expression (Saitou et al., 2002) . The BLIMP-1/PRMT-5 complex appears responsible for the progressive arginine residue symmetrical methylation of histone H2A/H4 (H2A/H4R3me2s), in PGCs from 8.5 to 11.5 dpc, a modification that may function in the transcriptional repression of target genes (Ancelin et al., 2006) . The different H2A/ H4R3me2s pattern between the Oct3/4-GFP weak and Oct3/4-GFP high populations observed by us supports the existence of heterogeneous BLIMP-1/PRMT-5-dependent chromatin signature between the two Oct3/4-GFP pos cell populations. In a recent paper, Hajakova and colleagues (Hajkova et al., 2008) identified in 11.5 dpc urogenital ridges, two PGC populations with low and high expression of the GOF-18ΔPE-GFP Pou5f1 transgene. On the basis of the chromatin signature, including altered modification of H2A/H4, these authors concluded that the cells with lower Oct3/4 expression were more undifferentiated PGCs that subsequently disappeared in 12.5 dpc gonads. Interestingly, in C. elegans pie-1 and gcl mutants if transcription is activated in PGC precursors, PGCs are not formed. If transcription is turned on after PGC formation, PGCs exhibit migration defects and die (nanos and pgc mutants), or reach the gonads but their descendents degenerate (mes mutants) (Blackwell, 2004; Schaner and Kelly, 2006) . Lineage analyses, however, have shown that loss of PGCs in C. elegans pie-1 mutants is due to transformation of the germ cell precursors to a somatic cell fate (Schaner and Kelly, 2006) . Similarly, inhibition of the cell death program in Drosophila Nanos mutants revealed that the dying pole cells express somatic markers, consistent with a germline-tosoma transformation (Hayashi et al., 2004) . A second possibility is that the heterogeneity of GOF-18ΔPE-GFP Pou5f1 transgene expression in PGCs, at this stage associated to that of BLIMP-1 and STELLA, might reflect an intrinsic stem cell metastability and plasticity similar to that reported in mouse embryonic stem (ES) cells also for other proteins such as PECAM-1, NANOG, SSEA-1 and STELLA itself (Chambers et al., 2007; Cui et al., 2004; Furusawa et al., 2004; Hayashi et al., 2008; Payer et al., 2006; Toyooka et al., 2008) . As for STELLA, Hayashi et al. (2008) showed that mouse ESCs are in a metastable state and shift between a STELLA negative and positive states while retaining pluripotency. This equilibrium can shift in either direction in response to a variety of environment factors, including epigenetic regulators and might allow a subset of cells to enter different cell lineages. Several lines of evidence suggest that PGCs retain the potential to convert back to a pluripotent state capable of generating somatic cell descendents. Early and more recent studies showed that PGCs can give rise to teratocarcinomas, embryonic tumors containing differentiated somatic cell types representative of all three germ layers and in vitro to pluripotent embryonal germ (EG) cells, similar to ESCs (for a review, see De Felici and Dolci, 2013) . Actually, early studies claimed that 8.5 dpc PGCs and EG cell lines can be induced to differentiate into hematopoietic cells when cultured in methylcellulose in the presence of IL-3 (Otaka et al., 1999; Rich, 1995) . Interestingly, Morita-Fujimura et al. (2009) and Matsui and Tokitake (2009) also claimed that PGCs are heterogeneous cells with distinct cellular properties. In fact, they found that mouse PGCs are heterogeneous for the expression of integrin α6 and c-KIT receptor; PGCs with negative or low integrin α6 expression and with side population (SP) cell phenotype have higher potential to convert to EG cells. Third, upregulation of Oct3/4 expression might be associated to progressive germline segregation while cells expressing low level of the transgene could represent an independent lineage of stem cells and/or hematopoietic progenitors forming along with the PGCs in the allantois and moving or originated in the AGM. In line with this possibility, PGC precursors are reported to emerge from epiblast cells together with hemogenic extraembryonic mesodermal cells (Hayashi et al., 2007; Huber et al., 2004) and Furuta et al. (2006) found PECAM-1 positive endothelial progenitors and CFU cells expressing Oct3/4 in 7.5-8.5 dpc embryo proper and yolk sac. The coexpression of several proteins and transcripts of presumptive PGC and hematopoietic precursors in the Oct3/4 expressing cells or in subset of this population, supports a common stem/progenitor cell pool rather than two independent lineages. Interestingly, PGCs have been reported to express EGFL-7, a secreted protein highly expressed by endothelial cells during embryonic development (Campagnolo et al., 2008) . Although several lines of evidence indicate that definitive hematopoiesis is autonomously initiated in the mouse AGM between 10 and 11 days of gestation, a contribution from yolk sac is also probable (for a review, see McGrath and Palis, 2005) . In line with this notion, we also found that higher hematopoietic activity was present in the Oct3/4-GFP neg in comparison with Oct3/4-GFP pos 10.5-11.5 dpc AGM cell populations. It is to be pointed out that these three possibilities are based on the dogma that irreversibly determined PGCs arise extragonadally but this, as stated by Mikedis and Downs (2014) , has never been formally demonstrated.
A further possibility related to the common stem/ progenitor cell pool hypothesis suggested by Mikedis and Downs (2014) , is that cells usually considered as PGCs might be part of a stem/progenitor cell pool exhibiting all know PGC markers, including OCT3/4, moving in the posterior region of the embryo along with the posterior end of the primitive streak and settled in the proximal allantois around 7.0-8.0 dpc. Such population, termed the Allantoic core domain (ACD), defined by Brachyury expression, appears to be able contribute to a wide range of somatic tissues that encompasses derivates of the three primary germ layers (Mikedis and Downs, 2012) . In support of this view, these authors report studies showing that AP positive and Oct3/4 expressing cells contribute to somatic allantois cells (Anderson et al., 2000) . Moreover, they state that OCT3/4 and STELLA proteins are not specific to the PGC migratory pathway but can be found in several sites outside of it until hindgut formation (Downs, 2008) ; STELLA and OCT3/4 positive cells actually localize to several embryonic tissues outside of the PGC route (Anderson et al., 2000; Downs, 2008; Mikedis and Downs, 2012; Payer et al. 2005) and seem able to contribute to multiple cell types, including hematopoietic cells, both in vivo and in vitro (Bosman et al., 2006; Furuta et al., 2006; Mikedis and Downs, 2012) . In this regard, another view claims that a population of Oct3/4 positive epiblast-derived stem cells termed very small embryonic like (VSEL) cells, sharing several markers of PGCs and HSCs, is deposited early during gastrulation in developing tissues, being a source of precursors for adult stem cells (Ratajczak et al., 2007 (Ratajczak et al., , 2008 .
Whatever hypotheses are correct, our data indicate that a cell population showing features of migratory PGCs moving toward the gonadal ridges contains a subset of cells that might contribute to hematopoietic lineage and raise new questions about germline specification.
4.
Materials and methods
Animals
CD-1 mice were obtained from our Animal House. Female CD-1 were mated with male transgenic mice (OG2) (Boiani et al., 2005; Yeom et al., 1996) expressing EGFP driven by the germcell specific promoter/enhancer region of the Oct3/4 gene (GOF18deltaPE-GFP) to produce F1 hybrids. Noon of the day of the vaginal plug was designated as embryo 0.5 day post coitum (dpc). Animals were housed in a standard animal facility with free access to food and water, in accordance with the guidelines for animal care at the University of Rome Tor Vergata.
4.2.
Cell preparation 8.5 dpc caudal region (CR) of mouse embryos containing allantois and proximal hindgut and 10.5-11.5 dpc aorta-gonadmesonephros (AGM), were dissected under a stereomicroscope and single cell suspensions were obtained as previously described (De Felici, 1998) . Briefly tissues were collected in Hepes-MEM (GIBCO/BRL) with 10% BSA, and incubated in trypsin-EDTA solution for 5 min at room temperature, followed by gentle pipetting.
In some experiments, for PGC isolation, the cell suspensions obtained from the AGM were processed for immunosorting using the TG-1 antibody as described in Pesce and De Felici (1995) .
Flow cytometry
Single cell preparations from CR and AGM were suspended in PBS with 5 mg/ml BSA and FACS analyzed for GFP expression and/or labeled with specific antibodies. Dead cells and debris were excluded from the plots by means of propidium iodide (PI) staining (2 µg/ml). In experiments with OG-2 mouse cells, FACS analyses of wild-type CD-1 tissues were performed as control to set gates for GFP fluorescence. Phycoerythrin (R-PE) conjugated antibodies against CD-34 (cat. n. 551386), CD-41 (cat. n. 561850), CD-45 (cat. n. 553068), SCA-1 (or Ly-6A/E; cat. n. 561076), were obtained from BD Pharmingen; unconjugated anti-FLK-1 from Abcam was revealed by Alexa568 secondary antibodies from Molecular Probe. All primary antibodies were used at the dilution indicated by the manufacturers (around 1 µg/10 6 cells). In order to determine the background level of fluorescence, cell suspensions were stained with fluorochrome conjugated Ig isotype controls (Pharmingen). FACS analyses were performed on a dual-laser fluorescence-activated cell sorter FACSCalibur (Becton Dickinson). The CellquestR program was used for acquisition and analysis. Normally 30.000 events were acquired for analysis. Cell sorting was performed on a FACSAria II (Becton Dickinson) interfaced with the FACSDiVa 6.0 Software. Purity of sorted population was always > of 98%.
Immunofluorescence analysis and AP hystochemistry
For immunofluorescence (IF) analyses, monodispersed or FACS sorted cells were transferred onto poly-L-lysine-coated glass slides and fixed with 3.5% paraformaldehyde, at room temperature, for 15-20 min. The cells were incubated for 1, 2 h at room temperature with 1:200-1/1000 dilution of the primary antibodies. The primary antibodies used were the following: from BD Pharmingen: FITC or R-PE conjugated anti-c-Kit (or CD117; cat. n. 5561680, 553869), R-PE anti-SCA-1 (or Ly-6A/E; cat. n. 561076), R-PE anti-PECAM-1 (or CD-31) (cat. n. 561073), R-PE (cat. n. 551386) or biotin conjugated anti-CD-34 (cat. n. 09432D); from Abcam: anti-BLIMP-1 (ab13700), anti-FLK-1 (ab2349) and anti-H2A/H4R3me2s (ab5823). TG-1 and anti-STELLA antibodies were kindly provided by Dr. P. Donovan and Dr. T. Kimura, respectively. Biotin conjugated antibodies were revealed using FITC or TRITC streptavidin-secondary antibodies (BD Pharmingen); staining from unconjugated antibodies was revealed with secondary FITC or TRITC antibodies (Sigma). Control experiments for indirect IF were performed using mouse or rat IgG as primary antibodies and or the secondary antibody only. After incubation cells were washed five times with PBS. To stain DNA, Hoechst dye 33258 (Sigma-Aldrich) was added for the last 2 min at a final concentration of 1 µg/ml, to identify nuclear morphologies. Cells were washed extensively in PBS and slides were mounted in 50% glycerol in PBS. Alkaline phosphatase (AP) cytochemistry was performed according to De Felici (1998) . In all analyses, cells were scored in a minimum of five fields under a 40× or 60× objective using an Axoplan II Zeiss microscope.
Short term hematopoietic colony-forming unit assay (CFU)
FACS sorted cell populations were plated in duplicate or triplicate at 10 3 -10 4 cells/ml in 35 mm tissue culture Falcon dish in Iscove's Modified Dulbecco's medium (Gibco-BRL) supplemented with 1% methylcellulose, 30% fetal calf serum (Gibco-BRL) in the presence of various cytokines: 100 ng/ml mouse SCF, 20 ng/ml mouse LIF, 3 ng/ml mouse IL-3 and 4 U/ml human EPO (R&D System). Cultures were maintained in a humidified incubator at 37°C in 5% CO2 in air. The formation of granulocyte (CFU-G), macrophage (CFU-M), erythroid (CFU-E), granulocyte/ macrophage (CFU-GM), mixed granulocyte/macrophage/ erythroid (CFU-Mix) and blastic colonies (BCs), was scored after 7-10 days of culture using an inverted phase contrast microscope.
RNA extraction and RT-PCR assay
Total RNA was extracted from sorted cells using the RNAeasy Plus kit (Qiagen), in accordance with the manufacturer's instructions. First-strand cDNA synthesis was performed as follows: 50 ng of total RNA was reverse transcribed by 50 U of Superscript™ II (Invitrogen) using 500 ng of random hexamers, in the presence of 0.5 µM deoxynucleotide triphosphates in a final volume of 25 µl. The reaction mixture was incubated for 1 h at 42°C and then heat denatured for 15 min at 75°C. DNA contamination or PCR carryover controls were performed omitting reverse transcriptase during reverse transcription step. One hundred microliters of cDNA was amplified using the following PCR conditions: 94°C for 1 min, 55°C for 1 min, 72°C for 1 min for 30 cycles. The following primers were used:
Hox b4 (Gene Bank accession NM_010459) Forward 5′-GCACGGTAAACCCCAATTA-3′ Reverse 5′-GGCAACTTGTGGTCTTTTTT-3′ T-Brachyury (Gene Bank accession NM_003181) Forward 5′-TGCTGCCTGTGAGTCATAAC-3′ Reverse 5′-ACCAAGGTGCTATATATTGCC-3′ Gata-2 (Gene Bank accession NM_008090) Forward 5′-CGCATGCCCGTCTCACCGGAG-3′ Reverse 5′-CGGCCTTCTGAGCAGGAGCGA-3′ Scl/Tal-1 (Gene Bank accession NM_003181) Forward 5′-TAGGAGATGGAGATTTCTGATG-3′ Reverse 5′-GCTCCTCTGTGTAACTGTCC-3′
Statistical analysis
All experiments were replicated at least three times. The means were tested for the homogeneity of variance and analyzed by ANOVA. Results are given as mean + standard error (SEM).
